DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
The Drug Risk Resource Center is the Web´s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com
New York, NY (PRWEB) January 24, 2013
The prescription drug resource center DrugRisk.com is alerting women who have used the vaginal ring contraceptive NuvaRing of new information added to the site showing trials are scheduled to begin this year for those claiming they suffered blood clots from the devices.
The mission of DrugRisk is to improve patient safety through education, including the latest drug warnings, recalls, studies and litigation news. “Many patients follow legal news for a drug they´re using to learn if others may be affected with similar problems and whether they have options,” explains DrugRisk representative Ryan Mayer.
DrugRisk contains warnings from experts linking vaginal rings like NuvaRing to higher blood clot risks than traditional birth control pills.
The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives.* On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.** Nevertheless, there has still been no NuvaRing recall.
DrugRisk has also learned that, due to the number of patients filing a NuvaRing lawsuit, cases have been consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.
Now, new information on the site shows that Judge Rodney Sippel, who is presiding over the federal court, has scheduled trials to begin on July 8, 2013.*** The latest U.S. Judicial Panel on MultiDistrict Litigation update showed NuvaRing lawsuits have risen by nearly 5% to 1076.****
This month, DrugRisk learned of research at Brigham and Women´s Faulkner Hospital which found that, while combined hormone vaginal ring contraceptives like NuvaRing can increase blood clot risks for all women, the risks are significantly higher for those suffering migraines.*****
Anyone who suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.
Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
***Order # 1423, Novenber 20, 2012, Case: 4:08-md-01964-RWS
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebnuvaring-recall/lawsuit-warnings/prweb10348434.htm